Factors underlying the early limb muscle weakness in acute quadriplegic myopathy using an experimental ICU porcine model

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Ochala, Julien ^a   Ahlbeck, Karsten ^b   Radell, Peter J ^b   Eriksson, Lars I ^b   Larsson, Lars ^a,c  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROMUSCULAR BLOCKING AGENT; ACTIN; CORTICOSTEROID; ENDOTOXIN; MYOSIN;

ACUTE QUADRIPLEGIC MYOPATHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CRITICALLY ILL PATIENT; ELECTROMYOGRAPHY; ELECTRONEUROGRAPHY; FEMALE; IMMOBILIZATION; INTENSIVE CARE UNIT; LEG MUSCLE; LIMB WEAKNESS; MOTOR NERVE CONDUCTION; MUSCLE ACTION POTENTIAL; MUSCLE BIOPSY; MUSCLE FIBER CONTRACTION; MUSCLE FORCE; MYOPATHY; NONHUMAN; PERONEUS NERVE; PIGLET; SEDATION; SEPSIS; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; ELECTROPHYSIOLOGY; LIMB; METABOLISM; MUSCLE CONTRACTION; MUSCLE WEAKNESS; PATHOLOGY; PATHOPHYSIOLOGY; QUADRIPLEGIA; SWINE; TIME;

ANIMALIA; SUS;

ACTINS; ADRENAL CORTEX HORMONES; ANIMALS; DISEASE MODELS, ANIMAL; ELECTROPHYSIOLOGICAL PROCESSES; ENDOTOXINS; EXTREMITIES; FEMALE; IMMOBILIZATION; INTENSIVE CARE UNITS; MUSCLE CONTRACTION; MUSCLE WEAKNESS; MYOSINS; NEUROMUSCULAR BLOCKING AGENTS; QUADRIPLEGIA; SEPSIS; SWINE; TIME FACTORS;

EID: 79958808182     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020876     Document Type: Article

References (29)

1. Hudson LD, Lee CM, (2003) Neuromuscular sequelae of critical illness. N Engl J Med 348: 745-747.
2. Bolton CF, (1996) Neuromuscular conditions in the intensive care unit. Intensive Care Med 22: 841-843.
3. Friedrich O, Hund E, Weber C, Hacke W, Fink RH, (2004) Critical illness myopathy serum fractions affect membrane excitability and intracellular calcium release in mammalian skeletal muscle. J Neurol 251: 53-65.
4. Larsson L, Li X, Edstrom L, Eriksson LI, Zackrisson H, et al. (2000) Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: mechanisms at the cellular and molecular levels. Crit Care Med 28: 34-45.
5. Ochala J, Larsson L, (2008) Effects of a preferential myosin loss on Ca2+ activation of force generation in single human skeletal muscle fibres. Exp Physiol 93: 486-495.
6. Friedrich O, (2006) Critical illness myopathy: what is happening? Curr Opin Clin Nutr Metab Care 9: 403-409.
7. Friedrich O, Fink RH, Hund E, (2005) Understanding critical illness myopathy: approaching the pathomechanism. J Nutr 135: 1813S-1817S.
8. Larsson L, (2007) Experimental animal models of muscle wasting in intensive care unit patients. Crit Care Med 35: S484-487.
9. Norman H, Kandala K, Kolluri R, Zackrisson H, Nordquist J, et al. (2006) A porcine model of acute quadriplegic myopathy: a feasibility study. Acta Anaesthesiol Scand 50: 1058-1067.
10. Radell PJ, Remahl S, Nichols DG, Eriksson LI, (2002) Effects of prolonged mechanical ventilation and inactivity on piglet diaphragm function. Intensive Care Med 28: 358-364.
11. Banduseela VC, Ochala J, Chen YW, Goransson H, Norman HS, et al. (2009) Gene expression and muscle fiber function in a porcine ICU model. Physiol Genomics.
12. Frontera WR, Larsson L, (1997) Contractile studies of single human skeletal muscle fibers: a comparison of different muscles, permeabilization procedures, and storage techniques. Muscle Nerve 20: 948-952.
13. Moss RL, (1979) Sarcomere length-tension relations of frog skinned muscle fibres during calcium activation at short lengths. J Physiol 292: 177-192.
14. Larsson L, Moss RL, (1993) Maximum velocity of shortening in relation to myosin isoform composition in single fibres from human skeletal muscles. J Physiol 472: 595-614.
15. Fabiato A, (1988) Computer programs for calculating total from specified free or free from specified total ionic concentrations in aqueous solutions containing multiple metals and ligands. Methods Enzymol 157: 378-417.
16. Edman KA, (1979) The velocity of unloaded shortening and its relation to sarcomere length and isometric force in vertebrate muscle fibres. J Physiol 291: 143-159.
17. Moss RL, (1986) Effects on shortening velocity of rabbit skeletal muscle due to variations in the level of thin-filament activation. J Physiol 377: 487-505.
18. Rich MM, Bird SJ, Raps EC, McCluskey LF, Teener JW, (1997) Direct muscle stimulation in acute quadriplegic myopathy. Muscle Nerve 20: 665-673.
19. Rich MM, Pinter MJ, (2001) Sodium channel inactivation in an animal model of acute quadriplegic myopathy. Ann Neurol 50: 26-33.
20. Rich MM, Pinter MJ, (2003) Crucial role of sodium channel fast inactivation in muscle fibre inexcitability in a rat model of critical illness myopathy. J Physiol 547: 555-566.
21. Rich MM, Pinter MJ, Kraner SD, Barchi RL, (1998) Loss of electrical excitability in an animal model of acute quadriplegic myopathy. Ann Neurol 43: 171-179.
22. Khan J, Harrison TB, Rich MM, (2008) Mechanisms of neuromuscular dysfunction in critical illness. Crit Care Clin 24: 165-177, x.
23. Lecker SH, Solomon V, Mitch WE, Goldberg AL, (1999) Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. J Nutr 129: 227S-237S.
24. Fitts RH, Romatowski JG, Peters JR, Paddon-Jones D, Wolfe RR, et al. (2007) The deleterious effects of bed rest on human skeletal muscle fibers are exacerbated by hypercortisolemia and ameliorated by dietary supplementation. Am J Physiol Cell Physiol 293: C313-320.
25. Schakman O, Gilson H, Kalista S, Thissen JP, (2009) Mechanisms of muscle atrophy induced by glucocorticoids. Horm Res 72 (Suppl 1): 36-41.
26. Schakman O, Gilson H, Thissen JP, (2008) Mechanisms of glucocorticoid-induced myopathy. J Endocrinol 197: 1-10.
27. Goldberg AL, Tischler M, DeMartino G, Griffin G, (1980) Hormonal regulation of protein degradation and synthesis in skeletal muscle. Fed Proc 39: 31-36.
28. Houstis N, Rosen ED, Lander ES, (2006) Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440: 944-948.
29. Reid MB, (2001) Nitric oxide, reactive oxygen species, and skeletal muscle contraction. Med Sci Sports Exerc 33: 371-376.